Anthem Biosciences Ltd (ANTHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039665,
    "name": "Anthem Bioscienc",
    "stock_name": "Anthem Bioscienc",
    "full_name": "Anthem Biosciences Ltd",
    "name_url": "stocks-analysis/anthem-bioscienc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "798.50",
    "chg": 30.75,
    "chgp": "4.01%",
    "dir": 1,
    "prev_price": "767.75",
    "mcapval": "44,971.13 Cr",
    "mcap": "Large Cap",
    "scripcode": 544449,
    "symbol": "ANTHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0CZ201020",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "17.37 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-to-mildly-bullish-amid-mixed-market-returns-4002245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_technicaldot_4002245.png",
        "date": "2026-05-21 08:04:48",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a recent day decline of 0.87%, the stock’s technical indicators reveal a complex picture of emerging strength tempered by caution, as investors weigh the implications of mixed signals from key momentum and volume metrics."
      },
      {
        "title": "Golden Cross Forms in Anthem Biosciences Ltd — Mixed Technical Signals Cloud the Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4001423",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_goldencross_4001423.png",
        "date": "2026-05-20 18:00:43",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Anthem Biosciences Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.87% on the day the cross formed, while monthly technical indicators remain inconclusive. This divergence between the moving averages and other signals calls for a nuanced analysis of the cross's reliability."
      },
      {
        "title": "Anthem Biosciences Downgraded to Sell Amid Technical Weakness and Financial Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-downgraded-to-sell-amid-technical-weakness-and-financial-setbacks-3998462",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_mojoScore_3998462.png",
        "date": "2026-05-19 09:11:12",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 18 May 2026. This shift reflects a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns, despite some positive long-term fundamentals and institutional interest."
      },
      {
        "title": "When is the next results date for Anthem Biosciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-anthem-biosciences-ltd-3990193",
        "imagepath": "",
        "date": "2026-05-13 23:17:43",
        "description": "The next results date for Anthem Biosciences Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Anthem Biosciences Gains 2.68%: Mixed Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-gains-268-mixed-signals-shape-weekly-momentum-3982596",
        "imagepath": "",
        "date": "2026-05-09 09:02:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.764.10</p>\n                    <p><strong>5 May:</strong> Stock dips 0.42% amid broader market weakness</p>\n                    <p><strong>6 May:</strong> Sharp rebound with 0.99% gain as Sensex rallies</p>\n                    <p><strong>7 May:</strong> Strong 1.37% rise following technical momentum shift</p>\n                    <p><strong>8 May:</strong> MarketsMOJO downgrades stock to Sell; closes at Rs.784.55 (+0.73%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.764.10</div></div>\n                    <div class=\"sta..."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-by-marketsmojo-3975778",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AnthemBioscienc_mojoScore_3975778.png",
        "date": "2026-05-05 10:10:17",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Anthem Biosciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-3960639",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_mojoScore_3960639.png",
        "date": "2026-04-24 10:10:16",
        "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 April 2026."
      },
      {
        "title": "Anthem Biosciences Gains 12.28%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-gains-1228-6-key-factors-driving-the-weeks-momentum-3942185",
        "imagepath": "",
        "date": "2026-04-11 09:02:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Mojo Grade downgraded to Sell amid technical and financial weakness</p>\n                    <p><strong>7 Apr:</strong> Technical momentum shifts to sideways trend with mixed signals</p>\n                    <p><strong>8 Apr:</strong> Mildly bullish momentum emerges with technical upgrades</p>\n                    <p><strong>9 Apr:</strong> Intraday high of ₹728.5 with a 5.83% surge</p>\n                    <p><strong>9 Apr:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>10 Apr:</strong> Technical momentum shifts to mildly bullish with strong price gains</p>\n                </div>\n\n                <div class=\"stats-row\">..."
      },
      {
        "title": "Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-sees-technical-momentum-shift-amid-strong-price-gains-3941032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AnthemBioscienc_technicaldot_3941032.png",
        "date": "2026-04-10 08:04:36",
        "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, signalling a cautiously optimistic outlook after a period of subdued performance. The stock’s recent 4.76% intraday gain to ₹722.70, coupled with upgrades in key technical parameters, suggests a mild bullish trend emerging in the near term."
      }
    ],
    "total": 15,
    "sid": "10039665",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/anthem-biosciences-10039665"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "05-Jun-2026",
      "details": "Schedule of Institutional Call to be held on June 10 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "22-May-2026",
      "details": "Earnings Call transcript for Earnings Call held on May 20 2026 for the Audited Standalone and Consolidated financial results for the quarter and year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "22-May-2026",
      "details": "Investors/Analyst Call Intimation to be schedule from June 02 2026 till June 05 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anthem Biosciences Ltd has declared <strong>100%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Anthem Biosciences Ltd Technical Momentum Shifts to Mildly Bullish Amid Mixed Market Returns

2026-05-21 08:04:48

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend. Despite a recent day decline of 0.87%, the stock’s technical indicators reveal a complex picture of emerging strength tempered by caution, as investors weigh the implications of mixed signals from key momentum and volume metrics.

Golden Cross Forms in Anthem Biosciences Ltd — Mixed Technical Signals Cloud the Outlook

2026-05-20 18:00:43

The 50-day moving average has crossed above the 200-day moving average for Anthem Biosciences Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.87% on the day the cross formed, while monthly technical indicators remain inconclusive. This divergence between the moving averages and other signals calls for a nuanced analysis of the cross's reliability.

Anthem Biosciences Downgraded to Sell Amid Technical Weakness and Financial Setbacks

2026-05-19 09:11:12

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 18 May 2026. This shift reflects a combination of deteriorating technical indicators, disappointing quarterly financial results, and valuation concerns, despite some positive long-term fundamentals and institutional interest.

When is the next results date for Anthem Biosciences Ltd?

2026-05-13 23:17:43

The next results date for Anthem Biosciences Ltd is scheduled for 19 May 2026....

Anthem Biosciences Gains 2.68%: Mixed Signals Shape Weekly Momentum

2026-05-09 09:02:46

Key Events This Week 4 May: Week opens at Rs.764.10 5 May: Stock dips 0.42% amid broader market weakness 6 May: Sharp rebound with 0.99% gain as Sensex rallies 7 May: Strong 1.37% rise following technical momentum shift 8 May: MarketsMOJO downgrades stock to Sell; closes at Rs.784.55 (+0.73%) Week OpenRs.764.10 <div class="sta...

Anthem Biosciences Ltd is Rated Hold by MarketsMOJO

2026-05-05 10:10:17

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Anthem Biosciences Ltd is Rated Hold

2026-04-24 10:10:16

Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. While the rating change occurred on that date, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 24 April 2026.

Anthem Biosciences Gains 12.28%: 6 Key Factors Driving the Week’s Momentum

2026-04-11 09:02:37

Key Events This Week 6 Apr: Mojo Grade downgraded to Sell amid technical and financial weakness 7 Apr: Technical momentum shifts to sideways trend with mixed signals 8 Apr: Mildly bullish momentum emerges with technical upgrades 9 Apr: Intraday high of ₹728.5 with a 5.83% surge 9 Apr: Technical momentum shifts amid mixed market signals 10 Apr: Technical momentum shifts to mildly bullish with strong price gains ...

Anthem Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Gains

2026-04-10 08:04:36

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has demonstrated a notable shift in price momentum and technical indicators, signalling a cautiously optimistic outlook after a period of subdued performance. The stock’s recent 4.76% intraday gain to ₹722.70, coupled with upgrades in key technical parameters, suggests a mild bullish trend emerging in the near term.

View All News